| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/22/2012 | CN101757450B 一种治疗骨病的膏药 A method of treating bone disease plaster |
| 02/22/2012 | CN101745065B 一种具有抗癌止痛作用的药物组合物 A pharmaceutical composition having an anticancer analgesic effect |
| 02/22/2012 | CN101716318B 一种用于辅助化疗方式治疗消化系统肿瘤的中药制剂 An adjuvant chemotherapy Chinese medicine for the treatment of digestive tumors way |
| 02/22/2012 | CN101708322B 治疗风湿疾病的药酒 Treatment of rheumatoid diseases wine |
| 02/22/2012 | CN101700331B 接骨灵喷雾剂 Bone Spirit sprays |
| 02/22/2012 | CN101642510B 一种治疗重症躁狂症的中药组合物及其制备方法 A severe mania Chinese medicine composition and its preparation method of treatment |
| 02/22/2012 | CN101612217B 一种中药组合物在制备治疗中心性浆液性脉络膜视网膜病变的药物中的应用 A composition for use in the preparation of traditional Chinese medicine treatment of Central serous retinopathy medicament |
| 02/22/2012 | CN101549077B 用于综合治疗小儿腹泻的中药制剂 For the comprehensive treatment of infantile diarrhea Chinese medicine |
| 02/22/2012 | CN101084996B 含有丹参的中药组合物及其制剂 Chinese medicine composition containing Salvia and its preparations |
| 02/22/2012 | CN101040935B 一种用于祛痰止咳的滴丸制剂及其制备方法 Dropping Pills and its preparation method for expectorant cough |
| 02/22/2012 | CN101002801B 一种增强免疫力的保健食品的制备方法 A method of preparing a health food to enhance immunity |
| 02/21/2012 | US8119774 Cell marker for hepatic and pancreatic stem cells and progenitor cells |
| 02/21/2012 | US8119772 Nucleic acid encoding polypeptide of given sequence; treatment of melanoma by administering transduced peripheral blood mononuclear cells |
| 02/21/2012 | US8119638 Compositions and uses of ET743 for treating cancer |
| 02/21/2012 | US8119608 Specific inhibition of expression of target gene in mammals using short double stranded RNA; dsRNA less than 49 nucleotides in length, has nucleotide sequence complementary to part of target gene; treating cancer, Alzheimer's disease |
| 02/21/2012 | US8119597 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 02/21/2012 | US8119590 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally |
| 02/21/2012 | US8119397 Therapeutic agents and therapeutic methods for treating injured tissue |
| 02/21/2012 | US8119395 Vaccines, immunotherapeutics and methods for using the same |
| 02/21/2012 | US8119167 Food supplement composition suitable for promoting iron absorption |
| 02/21/2012 | US8119138 Anti-estrogen and immune modulator combinations for treating breast cancer |
| 02/21/2012 | US8119123 Compositions comprising vascular and myocyte progenitor cells and methods of their use |
| 02/21/2012 | US8119122 Use of gingival fibroblasts for vascular cell therapy |
| 02/21/2012 | US8119121 Delivering a concentrated amount of stem cells obtained from adipose tissue to a patient |
| 02/21/2012 | US8119119 Retroviral vector for improving exogenous gene transfer and expression in cells |
| 02/21/2012 | CA2568995C Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 02/21/2012 | CA2510308C Process and compounds for preventing and/or treating sensitive and/or dry skin |
| 02/21/2012 | CA2495909C Nucleic acid damage using riboflavin and light |
| 02/21/2012 | CA2483908C Vascularization enhanced graft constructs |
| 02/21/2012 | CA2468933C Method for obtaining oestrogen from mare's urine |
| 02/21/2012 | CA2439123C Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 02/21/2012 | CA2407680C Dendritic cell co-stimulator molecules |
| 02/21/2012 | CA2406626C Hemostatically active vwf-containing preparation and process for the preparation thereof |
| 02/21/2012 | CA2386506C Isolation of precursor cells and their use for tissue repair |
| 02/21/2012 | CA2375557C Detachment surface |
| 02/21/2012 | CA2373300C Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 02/21/2012 | CA2362022C Methods of microencapsulating pancreatic islet cells |
| 02/21/2012 | CA2354045C New cancer treatments |
| 02/21/2012 | CA2350185C Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 02/21/2012 | CA2349760C Bovine cells expressing adeno virus essential functions for propagation of recombinant adenoviral vectors |
| 02/21/2012 | CA2302866C Genetically modified tumor-targeted bacteria with reduced virulence |
| 02/21/2012 | CA2297303C Novel peptides and polypeptides useful for regenerating the nervous system |
| 02/21/2012 | CA2264592C Bioconjugates and delivery of bioactive agents |
| 02/21/2012 | CA2213780C Pharmaceuticals containing multipotential precursor cells from tissues containing sensory receptors |
| 02/21/2012 | CA2158936C Compositions and methods for utilizing conditionally lethal genes |
| 02/16/2012 | WO2012021885A1 Three-dimensional tissue engineering devices and uses thereof |
| 02/16/2012 | WO2012021845A2 Improved hematopoietic stem and progenitor cell therapy |
| 02/16/2012 | WO2012021818A2 Ggf2 and methods of use |
| 02/16/2012 | WO2012021735A2 Pharmaceutical products from gungal strains |
| 02/16/2012 | WO2012021698A2 Treatment of diabetes with pancreatic endocrine precursor cells |
| 02/16/2012 | WO2012021578A1 Use of angiotensin- ii (1-7) in cell trans planation and as an agent for preventing/treating norovirus infection |
| 02/16/2012 | WO2012021016A2 Lacobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient |
| 02/16/2012 | WO2012020991A2 Composition for preventing and alleviating brain disease comprising silk amino acid and tyrosine as active ingredients |
| 02/16/2012 | WO2012020845A1 Method of producing pancreatic hormone-producing cells |
| 02/16/2012 | WO2012020757A1 Production method for cell populations |
| 02/16/2012 | WO2012020566A1 Highly functionalized stem cell/progenitor cell by ape1 gene transfection |
| 02/16/2012 | WO2012020370A1 Galvinoxyl derivative for use thereof against lipoprotein-enveloped viruses, in particular herpesviruses |
| 02/16/2012 | WO2012019295A1 Bioactive compounds in camel urine and milk |
| 02/16/2012 | WO2011154616A3 Use of abo type |
| 02/16/2012 | US20120040829 Bacterial ghosts as carrier and targeting vehicles |
| 02/16/2012 | US20120040014 LIPID Supplements for Maintaining Health and Treatment of Acute and Chronic Disorders |
| 02/16/2012 | US20120040013 Regenerative Tissue Scaffolds |
| 02/16/2012 | US20120040012 Therapeutic stem cell nutrient composition and uses thereof |
| 02/16/2012 | US20120039998 Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria |
| 02/16/2012 | US20120039982 Bio-Sheet for Eye Tissue Repair |
| 02/16/2012 | US20120039961 Implant and therapeutic composition for treating damage and/or diseases relating to the human animal musculoskeletal system |
| 02/16/2012 | US20120039956 Dry storage stabilizing composition for biological materials |
| 02/16/2012 | US20120039955 Treatment of Diabetes with Pancreatic Endocrine Precursor Cells |
| 02/16/2012 | US20120039950 Colostrum composition |
| 02/16/2012 | US20120039946 Immunopotentiating composition and process for producing same |
| 02/16/2012 | US20120039944 Whey and thymus function |
| 02/16/2012 | US20120039942 Outer membrane vesicles and uses thereof |
| 02/16/2012 | US20120039936 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 02/16/2012 | US20120039931 Dna composition encoding an immunogenic vegf receptor peptide and methods of use thereof |
| 02/16/2012 | US20120039877 E1-minus adenoviruses and use thereof |
| 02/16/2012 | US20120039860 Compositions and methods for improved oral health |
| 02/16/2012 | US20120039859 Method of Diminishing The Symptoms of Neurodegenerative Disease |
| 02/16/2012 | US20120039857 Systems and methods for cardiac tissue repair |
| 02/16/2012 | US20120039856 Composition for treating baldness with stem cell derived from umbilical cord blood |
| 02/16/2012 | US20120039855 Fibrin based scaffold, preparation and use thereof |
| 02/16/2012 | US20120039854 Nanoparticle Targeted Drug Delivery to the Lungs Using Extra-Testicular Sertoli Cells |
| 02/16/2012 | US20120039853 Cryoprotectants for freeze drying of lactic acid bacteria |
| 02/16/2012 | US20120039852 Lactobacillus rhamnosus ncc4007, a probiotic mixture and weight control |
| 02/16/2012 | US20120039851 Use of androgens for vascular regeneration and endothelial repair |
| 02/16/2012 | US20120039796 Novel method for creating, suspending and stabilizing electronically modified oxygen derivatives, along with creating, suspending and stabilizing electronically modified reaction intermediates, in a bio compatible fluorocarbon suspension, for the purpose of inducing a cascading immune response in mammalian patients |
| 02/16/2012 | CA2845280A1 Therapeutic uses of microvesicles and related micrornas |
| 02/16/2012 | CA2844474A1 Probiotic liquid food products |
| 02/16/2012 | CA2807944A1 Improved hematopoietic stem and progenitor cell therapy |
| 02/16/2012 | CA2807935A1 Method of producing pancreatic hormone-producing cells |
| 02/16/2012 | CA2807762A1 Methods for making a tissue engineered muscle repair (temr) construct in vitro for implantation in vivo |
| 02/16/2012 | CA2807158A1 Treatment of diabetes with pancreatic endocrine precursor cells |
| 02/15/2012 | EP2418484A2 Production process of gender-specific serum and biomarker using the serum |
| 02/15/2012 | EP2418272A1 New revascularization cells derived from mononuclear cells, and method of inducing differentiation thereof |
| 02/15/2012 | EP2418271A2 Methods and compositions for treatment of bone defects with placental cell populations |
| 02/15/2012 | EP2418214A1 Use of polypeptides against diseases caused by protozoans |
| 02/15/2012 | EP2417979A1 Beneficial effects of increasing local blood flow |
| 02/15/2012 | EP2417978A1 Beneficial effects of increasing local blood flow |
| 02/15/2012 | EP2417857A1 Method for manufacturing a colostrum product and device for executing the method |
| 02/15/2012 | EP2417258A1 Bacteriophage compositions for treatment of bacterial infections |
| 02/15/2012 | EP2416860A1 Method for producing and using active principles of limestone |